Literature DB >> 1067882

Screening for adrenal forms of hypertension.

L Baer.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 1067882      PMCID: PMC1807227     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  10 in total

1.  Extensive hypertensive work-up: pro.

Authors:  J C Melby
Journal:  JAMA       Date:  1975-01-27       Impact factor: 56.272

2.  Extensive hypertensive work-up: con.

Authors:  F A Finnerty
Journal:  JAMA       Date:  1975-01-27       Impact factor: 56.272

3.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

4.  Editorial: Hypertension control--the challenge of patient education.

Authors:  J B Stokes; G H Payne; T Cooper
Journal:  N Engl J Med       Date:  1973-12-20       Impact factor: 91.245

Review 5.  Evaluation and care of the hypertensive patient.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

6.  Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism.

Authors:  L Baer; S C Sommers; L R Krakoff; M A Newton; J H Laragh
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

7.  Renal and renovascular hypertension. A reasoned approach to diagnosis and management.

Authors:  J C Hunt; S G Sheps; E G Harrison; C G Strong; P E Bernatz
Journal:  Arch Intern Med       Date:  1974-06

8.  Actual incidence of secondary hypertension.

Authors:  O Iimura
Journal:  Jpn Circ J       Date:  1973-09

9.  The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. A review of ten years' experience.

Authors:  S E Gitlow; M Mendlowitz; L M Bertani
Journal:  Am J Cardiol       Date:  1970-09       Impact factor: 2.778

10.  The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism.

Authors:  N M Kaplan
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.